Trials / Completed
CompletedNCT00403962
A Combination Therapy In Patients With Social Anxiety Disorder
A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Fixed Dose Study Comparing the Efficacy and Safety of GW597599/Paroxetine Combination or Paroxetine Monotherapy to Placebo in Patients With Social Anxiety Disorder (SAD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 204 (planned)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of a combination of Vestipitant and Paroxetine in patients with Social Anxiety Disorder (SAD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vestipitant/paroxetine |
Timeline
- Start date
- 2004-11-01
- Completion
- 2005-08-01
- First posted
- 2006-11-27
- Last updated
- 2016-09-15
Locations
17 sites across 4 countries: Denmark, Germany, Norway, South Africa
Source: ClinicalTrials.gov record NCT00403962. Inclusion in this directory is not an endorsement.